Share this article
Share this article
SEATTLE, April 7, 2021 /PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at 3:00 p.m. EST. The conference will be held in a virtual meeting format.
Presentation details:
Date: Wednesday, April 14, 2021
Time: 3:00 p.m. EST
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma s website at www.ctibiopharma.com.
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active
Share this article
Share this article
SEATTLE, March 31, 2021 /PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) ( CTI ), a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers, today announced the pricing of its previously announced underwritten public offering of 14,260,800 shares of its common stock and 600 shares of its series X
1 preferred stock (the Series X
1 Preferred ). In addition, CTI has granted the underwriters a 30-day option to purchase up to an additional 2,139,120 shares of its common stock on the same terms and conditions. The offering price to the public of a share of common stock is $2.50 and the offering price to the public of a share of Series X
CTI BioPharma Corp Announces Pricing of its Public Offering of Common Stock and Preferred Stock apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 09, 2021 - read this article along with other careers information, tips and advice on BioSpace